ArticleAmerican journal of ophthalmology2025
Surgical Dosing for Correction of Consecutive Exotropia.
Article in American journal of ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
purposeBecause surgical tables have not previously been available for consecutive exotropia, this study aimed to determine the appropriate surgical dosing for medial rectus (MR) advancement in this condition.
designRetrospective case series.
methodsData were reviewed for patients with consecutive exotropia who underwent MR advancement with or without lateral rectus (LR) recession.
resultsA total of 44 patients were included averaging 35 ± 20 (stamdard deviation ) years of age. Mean preoperative exotropia was 29 ± 15∆ at distance and 33 ± 19∆ at near. Thirty-four patients underwent unilateral or bilateral MR advancement, and 10 patients underwent MR advancement combined with LR recession. For the MR advancement group, mean advancement was 4.9 ± 1.4 mm. At the last follow-up visit, exotropia at distance was reduced from 26 ± 12∆ to 7 ± 11∆. For the MR advancement + LR recession group, mean MR advancement was 6.2 ± 2.0 mm, and the mean total surgical dose, including LR recession, was 14.6 ± 4.7 mm. Overall, distance exotropia at last follow-up was surgically reduced from 39 ± 18∆ to 9 ± 14∆. Exodrift from initial to final follow-up was 6.6∆ for MR advancement alone and 7.5∆ for MR advancement + LR recession. Regression analysis of surgical dose-response suggests that each MR advancement should be augmented by 2 mm more than Parks' general surgical recommendation for treating exotropia by MR resection.
conclusionsAugmentation of MR advancement may improve the correction of consecutive exotropia and is effective while affording opportunity to explore the MR muscle.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.